Showing 4,681 - 4,700 results of 14,107 for search '(( significant decrease decrease ) OR ( significant ((i decrease) OR (a decrease)) ))~', query time: 0.54s Refine Results
  1. 4681

    Image1_RETRACTED: miR-16 and Fluoxetine Both Reverse Autophagic and Apoptotic Change in Chronic Unpredictable Mild Stress Model Rats.tif by Yang Yang (45629)

    Published 2025
    “…An open field test and sucrose preference quantification displayed a significant decrease in the CUMS groups when compare to the control groups, however these changes were attenuated by both miR-16 and Fluoxetine treatments. …”
  2. 4682

    The long-term <i>in vitro</i> surrogate bacterial viability of canine and feline FMT products frozen at -80°C for six months. by Nina K. Randolph (21030732)

    Published 2025
    “…<p>All canine FMT products exhibited a significant decrease in overall bacterial viability at the six-month timepoint. …”
  3. 4683

    <i>PSAT1</i> gene as a biomarker for targeting triple negative breast cancer in presence of Rapamycin by Mehdi Roshanian Bakhsh (22469915)

    Published 2025
    “…In the presence of 3000 µg/mL Rapamycin, there was a sharp decrease in MDA-MB-468 cell viability (<i>p</i> ≤<i> 0.0001</i>) and a significant increase in apoptosis compared to MCF-7 cells treated with the same concentration of the drug. …”
  4. 4684

    Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α<sub>1</sub>‑Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents by Chaoquan Tian (21009122)

    Published 2025
    “…Compared with <b>Tam</b>, the potency of compound <b>10</b> against α<sub>1A</sub>-, α<sub>1B</sub>-, and α<sub>1D</sub>-AR decreased by 118-fold, 642-fold, and 10,000-fold, respectively. …”
  5. 4685

    Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α<sub>1</sub>‑Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents by Chaoquan Tian (21009122)

    Published 2025
    “…Compared with <b>Tam</b>, the potency of compound <b>10</b> against α<sub>1A</sub>-, α<sub>1B</sub>-, and α<sub>1D</sub>-AR decreased by 118-fold, 642-fold, and 10,000-fold, respectively. …”
  6. 4686

    Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α<sub>1</sub>‑Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents by Chaoquan Tian (21009122)

    Published 2025
    “…Compared with <b>Tam</b>, the potency of compound <b>10</b> against α<sub>1A</sub>-, α<sub>1B</sub>-, and α<sub>1D</sub>-AR decreased by 118-fold, 642-fold, and 10,000-fold, respectively. …”
  7. 4687

    GluA1 promotes opioid use by Yuan-Yuan Hou (11896051)

    Published 2025
    “…In rats with steady MSA, the protein level of GluA1 subunits of glutamate AMPA receptors (AMPARs) was significantly increased, but that of GluA2 was decreased, resulting in an increased GluA1/GluA2 ratio in central nucleus of the amygdala (CeA). …”
  8. 4688

    Source data file. by Laura Mora-Bitria (20477525)

    Published 2024
    “…Our results were validated in an independent data set. We conclude that iKIRs significantly decrease HLA class II protective associations and suggest that iKIRs regulate CD4<sup>+</sup> T cell responses in T1D.…”
  9. 4689

    Supporting data file. by Laura Mora-Bitria (20477525)

    Published 2024
    “…Our results were validated in an independent data set. We conclude that iKIRs significantly decrease HLA class II protective associations and suggest that iKIRs regulate CD4<sup>+</sup> T cell responses in T1D.…”
  10. 4690

    Demographic and ocular features. by Mingxi Shao (10066570)

    Published 2025
    “…Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H<sub>2</sub>O<sub>2</sub> (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”
  11. 4691

    Machine learning model to diagnose PCG. by Mingxi Shao (10066570)

    Published 2025
    “…Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H<sub>2</sub>O<sub>2</sub> (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”
  12. 4692

    ROC curves of TAS + SOD + MDA to diagnose PCG. by Mingxi Shao (10066570)

    Published 2025
    “…Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H<sub>2</sub>O<sub>2</sub> (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”
  13. 4693

    A rapid behavioral toxicity test using common periwinkle <i>Littorina littorea</i> (Gastropoda: Littorinidae) by Bjørn Henrik Hansen (1636042)

    Published 2025
    “…The exposure resulted in a concentration-dependent decrease in active suction, with snails retracting into their shells, which significantly reduced their oxygen consumption, indicating avoidance behavior. …”
  14. 4694
  15. 4695

    MDSC inhibition was correlated with Trp metabolism in 17ZR101-infected lungs. by Qi Xu (134661)

    Published 2025
    “…(e) KEGG pathway-based quantitative enrichment analysis indicating the most affected metabolic pathways in hv<i>Kp</i> infection. (f) Volcano plot analysis of the significantly increased or decreased metabolites. n=6/group. …”
  16. 4696

    Findings of the study. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  17. 4697

    PRISMA Flowchart. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  18. 4698

    General description of the study. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  19. 4699

    Quality Assessment. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  20. 4700

    Inclusion and exclusion criteria. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”